drugset
Drugs / MK0767
last change Dec 2003 re-read 2 minutes ago

MK0767

Small molecule targets PPARA, PPARG via activation

Developed for
type 2 diabetes mellitus · diabetes mellitus · hyperlipidemia · metabolic syndrome X
Investigated by
Merck Sharp & Dohme LLC

Trials 10 · a red edge is where a trial was stopped

today NCT00543816 · Ph 3 NCT00547274 · Ph 3 NCT00543738 · Ph 3 NCT00543491 · Ph 3 NCT00543361 · Ph 3 NCT00543517 · Ph 3 NCT00543751 · Ph 3 NCT00543010 · Ph 3 NCT00703690 · Ph 2 NCT00543556 · Ph 2
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 22 trials
Phase 2 NCT00703690 Jan 2002 → Dec 2003 metabolic syndrome X Merck Sharp & Dohme LLC Terminated No outcome recorded
Phase 2 NCT00543556 Oct 2001 → Nov 2003 type 2 diabetes mellitus Merck Sharp & Dohme LLC Terminated No outcome recorded
Phase 38 trials
Phase 3 NCT00543816 Aug → Nov 2003 type 2 diabetes mellitus Merck Sharp & Dohme LLC Terminated No outcome recorded
Phase 3 NCT00547274 Jul → Nov 2003 hyperlipidemia, type 2 diabetes mellitus Merck Sharp & Dohme LLC Terminated No outcome recorded
Phase 3 NCT00543738 Jun → Dec 2003 diabetes mellitus Merck Sharp & Dohme LLC Terminated No outcome recorded
Phase 3 NCT00543491 May → Dec 2003 type 2 diabetes mellitus Merck Sharp & Dohme LLC Terminated No outcome recorded
Phase 3 NCT00543361 May → Dec 2003 type 2 diabetes mellitus Merck Sharp & Dohme LLC Terminated No outcome recorded
Phase 3 NCT00543517 Feb → Nov 2003 type 2 diabetes mellitus Merck Sharp & Dohme LLC Terminated No outcome recorded
Phase 3 NCT00543751 Jan → Nov 2003 type 2 diabetes mellitus Merck Sharp & Dohme LLC Terminated No outcome recorded
Phase 3 NCT00543010 Nov 2002 → Nov 2003 type 2 diabetes mellitus Merck Sharp & Dohme LLC Terminated No outcome recorded

Evidence & citations 5 cited values

Every value below carries the sentence it was read from. 11 sources stand behind the page.

FieldValueCited text
Known as MK0767 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00543738 ↗
9

NCT00543556 ↗

NCT00543010 ↗

NCT00543361 ↗

NCT00547274 ↗

NCT00543751 ↗

NCT00543517 ↗

NCT00703690 ↗

NCT00543816 ↗

NCT00543491 ↗
Action Activate “Peroxisome proliferator-activated receptor gamma agonist” CHEMBL4297404 ↗
1

“Peroxisome proliferator-activated receptor alpha agonist” CHEMBL4297404 ↗
Modality Small molecule — CHEMBL4297404 ↗
Target PPARA “Peroxisome proliferator-activated receptor alpha agonist” CHEMBL4297404 ↗
Target PPARG “Peroxisome proliferator-activated receptor gamma agonist” CHEMBL4297404 ↗